Trial With Rhinitic Patients Taking GSK256066 Versus Placebo In A Pollen Challenge Chamber

NCT00377728 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Rhinitis, Allergic, Seasonal
Seasonal Allergic Rhinitis

Interventions

DRUG: GSK256066

Sponsor

GlaxoSmithKline